Cycloserine

What is Cycloserine?

Cycloserine is an antibiotic medication primarily used for tuberculosis, particularly multi-drug resistant tuberculosis (MDR-TB). It's an antitubercular drug reserved when first-line treatments fail. Beyond Mycobacterium tuberculosis, Cycloserine can also treat severe urinary tract infections (UTIs) caused by susceptible bacteria resistant to other antibiotics. Discovered in the 1950s, its unique mechanism of action makes it a valuable, albeit complex, second-line agent, known for potential central nervous system (CNS) side effects.

How Does it Work?

The efficacy of Cycloserine stems from its unique ability to disrupt bacterial cell wall synthesis. It acts as a structural analogue of D-alanine, an amino acid vital for forming the peptidoglycan layer of the bacterial cell wall. Cycloserine competitively inhibits two key enzymes: D-alanine racemase and D-alanine:D-alanine ligase. By blocking these enzymes, it prevents the formation of the D-alanine-D-alanine dipeptide, halting the synthesis of the peptidoglycan precursor. This disruption weakens the bacterial cell wall, leading to bacterial lysis and death, particularly effective against slow-growing bacteria like Mycobacterium tuberculosis.

Medical Uses

Cycloserine's primary medical use is in tuberculosis treatment, especially for strains resistant to first-line drugs like isoniazid and rifampicin. It's an essential component of regimens for drug-resistant TB, including MDR-TB and extensively drug-resistant tuberculosis (XDR-TB), always used in combination with other anti-TB agents to enhance efficacy and prevent further resistance. Due to potential serious side effects, it's reserved for challenging cases. Additionally, Cycloserine may treat urinary tract infections caused by susceptible bacteria resistant to other antibiotics. Its limited broad-spectrum activity makes it a consideration in specific, difficult-to-treat infections under strict medical supervision.

Dosage

The dosage of Cycloserine must be carefully individualized by a healthcare professional, considering renal function, body weight, and the specific infection. For adults, an initial dose for tuberculosis is typically 250 mg twice daily, gradually increasing based on response and tolerance, up to a maximum of 1 gram per day, often divided. Therapeutic drug monitoring is frequently used to optimize efficacy and minimize neuropsychiatric side effects. Patients with impaired kidney function need significant dose reductions to prevent drug accumulation and increased toxicity. Strict adherence to the prescribed dosage is crucial; do not discontinue without a doctor's consultation, even if symptoms improve, to ensure complete eradication and prevent resistance.

Side Effects

Cycloserine is associated with various side effects, with neuropsychiatric side effects being the most prominent and common reason for discontinuation. These can include headaches, dizziness, confusion, anxiety, depression, psychosis, seizures, and even suicidal ideation. The risk is dose-dependent and higher with elevated plasma concentrations, especially in patients with renal impairment or a history of mental health disorders. Other potential side effects include gastrointestinal issues like nausea, vomiting, abdominal pain, and diarrhea. Allergic reactions are rare. Due to severe CNS effects, pyridoxine (Vitamin B6) supplementation is often prescribed to help mitigate some neurological toxicities. Close medical monitoring is essential.

Drug Interactions

Cycloserine can interact with several medications. Co-administration with ethionamide can heighten the risk and severity of neuropsychiatric side effects, including seizures. Alcohol consumption should be strictly avoided, as it elevates the risk of neurological toxicity and seizures. Other central nervous system depressants (sedatives, tranquilizers) may potentiate Cycloserine's CNS effects, leading to increased drowsiness or confusion. Concurrent use with isoniazid can also increase CNS toxicity. Patients must inform their doctor about all prescription, over-the-counter, and herbal supplements to prevent dangerous drug interactions.

FAQ

What is Cycloserine primarily used for?

Cycloserine is mainly used for multi-drug resistant tuberculosis (MDR-TB) and extensively drug-resistant tuberculosis (XDR-TB), and sometimes for severe urinary tract infections resistant to other antibiotics.

How does Cycloserine work?

It works by inhibiting bacterial cell wall synthesis, specifically by blocking enzymes (D-alanine racemase and D-alanine:D-alanine ligase) essential for peptidoglycan formation, leading to bacterial death.

What are its most serious side effects?

The most serious side effects are neuropsychiatric side effects, including anxiety, depression, psychosis, and seizures, which are dose-dependent.

Is Cycloserine a first-line TB treatment?

No, it is a second-line or third-line antitubercular drug, reserved for cases where first-line treatments are ineffective due to resistance or intolerance.

Why is Vitamin B6 often prescribed with Cycloserine?

Pyridoxine (Vitamin B6) supplementation is often prescribed to help reduce the incidence and severity of some of Cycloserine's neurological toxicities.

Products containing Cycloserine are available through trusted online pharmacies. You can browse Cycloserine-based medications at ShipperVIP or Medicenter.

Summary

Cycloserine is a crucial antitubercular drug primarily used in the challenging treatment of drug-resistant TB, including MDR-TB and XDR-TB. Its unique action targets bacterial cell wall synthesis, making it effective against Mycobacterium tuberculosis and certain other resistant bacteria causing urinary tract infections. Despite its efficacy, its use is carefully managed due to a significant risk of neuropsychiatric side effects, requiring close patient monitoring, individualized dosing, and often concurrent pyridoxine supplementation. Vigilance regarding potential drug interactions is essential. Cycloserine remains an indispensable agent in the global fight against resistant infectious diseases.